Pre-INDs for Topical Microbicides

Products to Prevent Vaginal Transmission 
of Sexually Transmitted Diseases

How Do I Obtain Further Information Regarding Pre-IND Submissions for Topical Microbicide Antiviral Products?

For Pre-IND submissions and/or guidance, the working group functions closely with the Division of Antiviral Products (DAVP) Pre-IND Consultation Program; general information regarding Pre-IND submissions, including submissions for Topical Microbicide Products and points of contact, can be found at the DAVP’s Getting Started Page of the DAVP Pre-IND Consultation Program, and at additional resources and suggested links for Topical Microbicide Development.

Additional Information and Resources Regarding Pre-IND Drug Development for Topical Microbicide Products:

For information regarding both general and specific regulatory/scientific areas, additional resources and suggested links are available.

Note: DAVP Pre-IND interactions should be considered as preliminary communications based on early development information, and will generally take the form of written comments that may be supplemented by teleconferences or meetings as needed and appropriate. Additions or modifications to these communications may arise, as additional information becomes available, during follow-up Pre-IND interactions or when an IND is established.

Please direct any comments regarding DAVP Pre-IND/Topical Microbicide Web Pages to anthony.decicco@fda.hhs.gov.

PDF requires the free Adobe Acrobat Reader

Back to Top       Back to OAP Pre-IND Home

Date created: November 17, 2004, updated December 13, 2005

CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | Privacy | Accessibility | HHS Home Page

FDA/Center for Drug Evaluation and Research